Lexington, Massachusetts Clinical Trials

A listing of Lexington, Massachusetts clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 77 clinical trials
REEV SENSE for Gait Analysis in Post-stroke Gait Impairment (SENS-AG) (SENS-AG)

The purpose of this study is to evaluate the clinical performance of the investigational REEV SENSE gait tracker to measure gait features in subjects with post-stroke gait impairment. REEV SENSE is intended to be used by trained healthcare professionals as a simple procedure adapted to clinical routine. The reference method …

MIT Center for Clinical and Translational Research
 (8.5 away) Contact site
  • 0 views
  • 31 Jan, 2024
  • 1 location
RLY-1971 in Subjects With Advanced or Metastatic Solid Tumors

This study is a multi-center, open-label, dose escalation study of RLY-1971 in subjects with advanced or metastatic solid tumors.

hair thinning
solid tumor
neuropathy
solid tumour
metastatic malignant solid tumor
Dana Farber Cancer Center
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
A Trial of Traffic Light Labeling With Behavioral Nudges and a Healthy Recipe Database to Increase Selection of Healthier Foods in Client-choice Food Pantries

This study is a pilot evaluation of the Healthy Pantry Program, a new behavioral economics-based training that allows pantry staff to learn how to implement nudges integrating traffic-light nutrition labeling and a healthy recipe database in the pantry environment. The hypothesis is that participation the Healthy Pantry Program will lead …

Massachusetts General Hospital
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Treatment of Pregnant Women With OUD

The investigators are testing two models of support for pregnant women with an opioid use disorder (OUD)

Beth Israel Deaconess Medical Center
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +11 other locations
Study to Assess AFM24 in Advanced Solid Cancers

AFM24-101 is a first in human Phase 1/2a open-label, non-randomized, multi-center, multiple ascending dose escalation/expansion study evaluating AFM24 as monotherapy in patients with advanced solid malignancies whose disease has progressed after treatment with previous anticancer therapies. There will be two parts to this study: a dose escalation phase (1) and …

cancer
EGFR
small cell lung cancer
metastatic colorectal cancer
solid tumour
Dana Faber Cancer Institute
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
Efficacy of Near-Infrared Vein Imaging for Difficult IV Placement

The objective of this project is to define the effectiveness and therefore the role of NIR vein finders in adult patients with difficult peripheral venous access. The specific objective of the proposed randomized controlled trial is to test the clinical success rate of placing peripheral venous catheters in 'difficult' access …

Lahey Clinic
 (2.3 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

This study will assess the safety, efficacy, and pharmacokinetics of DS-6157a in participants with advanced gastrointestinal stromal tumors (GIST).

major surgery
pdgfra d842v mutation
growth factor
tyrosine
gilbert's syndrome
Dana Farber Cancer Institute
 (9.5 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +1 other locations
A Study of LY3819253 (LY-CoV555) in Participants Hospitalized for COVID-19

The purpose of this study is to test the safety and tolerability of LY3819253 when it is given by injection into a vein to participants hospitalized with COVID-19. Blood tests will be done to check how much LY3819253 is in the bloodstream and how long the body takes to eliminate …

covid-19
blood test
Massachusetts General Hospital
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +10 other locations
JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations

This is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.

ipilimumab
serum pregnancy test
non-small cell lung cancer
experimental therapy
alt/ast
Massachusetts General Hospital Cancer Center
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations
A Study of LY3819253 (LY-CoV555) in Participants With Mild to Moderate COVID-19 Illness

The purpose of this study is to measure how well LY3819253 works against the virus that causes COVID-19. LY3819253 will be given to participants with early symptoms of COVID-19, via an injection into a vein. Samples will be taken from the back of the nose to determine how much virus …

heart disease
sickle cell anemia
cough
cardiovascular disease
dyspnea
Massachusetts General Hospital
 (9.9 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +61 other locations